$
Federal Contract Award
Novartis Pharmaceuticals Corporation
Department of Veterans Affairs · September 28, 2026 · FY2026
36C26126F0168Set-aside not reportedNAICS 325412
Obligated
$1,200,299
Contract details
- Award ID
- CONT_AWD_36C26126F0168_3600_36F79720D0180_3600
- PIID
- 36C26126F0168
- Period of performance
- April 1, 2026 → September 30, 2026
- Place of performance
- MATHER, CA, USA
- Set-aside
- Not reported
- Pricing type
- FIRM FIXED PRICE
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- NAICS
- 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
Scope
PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML
Parent vehicle (IDV)
Novartis Sanierungsstiftung
UEI YE3YG1FDWMC5
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Novartis Pharmaceuticals Corporation →- UEI
- NG61ZA8TADW3
- CAGE
- 04520
- Parent
- Novartis Sanierungsstiftung
- Address
- EAST HANOVER, NJ
Awarding agency
Department of Veterans Affairs →- Sub-agency
- Department of Veterans Affairs
- Office
- 261-NETWORK CONTRACT OFFICE 21 (36C261)
- Funding agency
- Department of Veterans Affairs
- Funding office
- 261-NETWORK CONTRACT OFFICE 21 (36C261)
See every contract Novartis Pharmaceuticals Corporation has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Novartis Pharmaceuticals Corporation profile →